Change search
ReferencesLink to record
Permanent link

Direct link
The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics. School of Paediatrics and Child Health, Centre for Child Health Research, University of Western Australia, Perth .
Show others and affiliations
2012 (English)In: Allergy. European Journal of Allergy and Clinical Immunology, ISSN 0105-4538, E-ISSN 1398-9995, Vol. 67, no 1, 50-57 p.Article in journal (Refereed) Published
Abstract [en]

Background: Dietary changes may epigenetically modify fetal gene expression during critical periods of development to potentially influence disease susceptibility. This study examined whether maternal and/or fetal folate status in pregnancy is associated with infant allergic outcomes.

Methods: Pregnant women (n = 628) were recruited in the last trimester of pregnancy. Folate status determined by both food frequency questionnaires and folate levels in maternal and cord blood serum was examined in relation to infant allergic outcomes at 1 year of age (n = 484).

Results: Infants who developed allergic disease (namely eczema) did not show any differences in cord blood or maternal folate levels compared with children without disease. Although maternal folate intake from foods was also not different, folate derived from supplements was higher (= 0.017) in children with subsequent eczema. Furthermore, infants exposed to >500 μg folic acid/day as a supplement in utero were more likely to develop eczema than those taking <200 μg/day (OR [odds ratio] = 1.85; 95% CI 1.14–3.02;= 0.013), remaining significant after adjustment for maternal allergy and other confounders. There was a nonlinear relationship between cord blood folate and sensitization, with folate levels <50 nmol/l (OR = 3.02; 95% CI 1.16–7.87; = 0.024) and >75 nmol/l (OR = 3.59; 95% CI 1.40–9.20; = 0.008) associated with greater sensitization risk than levels between 50 and 75 nmol/l.

Conclusion: Fetal levels between 50 and 75 nmol/l appeared optimal for minimizing sensitization. While folate taken as a supplement in higher doses during the third trimester was associated with eczema, there was no effect on other allergic outcomes including sensitization. Further studies are needed to determine the significance of this.

Place, publisher, year, edition, pages
Copenhagen: Munksgaard , 2012. Vol. 67, no 1, 50-57 p.
Keyword [en]
allergic disease;allergy;diet;diet supplements;eczema;epigenetics;folate, cord blood;infants;pregnancy
National Category
URN: urn:nbn:se:umu:diva-49289DOI: 10.1111/j.1398-9995.2011.02714.xPubMedID: 21923665OAI: diva2:454196
Available from: 2011-11-06 Created: 2011-11-06 Last updated: 2015-03-31Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
West, Christina
By organisation
In the same journal
Allergy. European Journal of Allergy and Clinical Immunology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 43 hits
ReferencesLink to record
Permanent link

Direct link